Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Movement in US Dollar Bonds | SHIMAO Group SHIMAO 2 01/21/34 price fell by 15.114% to 2.281.
22/09/2025
On September 22, SHIMAO 2 01/21/34 issued by Shimao Group has a current price of 2.281, a decrease of -15.114%, and a return rate of 92.891%.
Latest
2 m ago
Golden Crown Electrical: Wins bid for 28.4029 million yuan State Grid project.
2 m ago
On September 22nd, the London Metal Exchange copper inventory was 145,375 tons, a decrease of 2,275 tons; aluminum inventory was 513,900 tons, unchanged; nickel inventory was 228,900 tons, an increase of 456 tons; zinc inventory was 46,825 tons, a decrease of 1,000 tons; lead inventory was 221,675 tons, an increase of 1,375 tons; tin inventory was 2,580 tons, an increase of 75 tons.
2 m ago
Li Yunze, head of the Financial Regulatory Bureau: Expand the coverage of the policy of non-repayment and loan renewal, involving loans of 9.4 trillion yuan.
2 m ago
South China Food: Net profit attributable to parent company in August decreased by 98.31% year-on-year.
3 m ago
Yabao Pharmaceutical: Terminates SY-009 Clinical Trial and Makes Provision for Impairment, Will Reduce Total Profit for 2025 by 55.79 million yuan.
See all latest